Literature DB >> 6408306

Inhibition by L-phenylalanine of tryptophan transport by synaptosomal plasma membrane vesicles: implications in the pathogenesis of phenylketonuria.

E Herrero, M C Aragon, C Gimenez, F Valdivieso.   

Abstract

Phenylalanine is accumulated in the genetically linked deficiency phenylketonuria. The effect of L-phenylalanine on the transport of tryptophan was studied using membrane vesicles from rat-brain synaptosomes. Phenylalanine at similar concentrations to those found in phenylketonuric patients competitively inhibits tryptophan uptake, with a Ki of the same order as the Km for tryptophan. This inhibition could be responsible for the depletion of serotonin found in phenylketonuria.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408306     DOI: 10.1007/BF02391190

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  27 in total

1.  Kinetic analysis of phenylalanine-induced inhibition in the saturable influx of tyrosine, tryptophan, leucine and histidine into brain cortex slices from adult and 7-day-old rats.

Authors:  M L Vahvelainen; S S Oja
Journal:  J Neurochem       Date:  1975-05       Impact factor: 5.372

2.  The effect of high concentrations of histidine on the level of other amino acids in plasma and brain of the mature rat.

Authors:  L A Tyfield; J B Holton
Journal:  J Neurochem       Date:  1976-01       Impact factor: 5.372

3.  Regulation of serotonin biosynthesis in brain: role of the high affinity uptake of tryptophan into serotonergic neurons.

Authors:  A J Mandell; S Knapp
Journal:  Fed Proc       Date:  1977-07

4.  Transport of tryptophan and tyrosine in rat brain slices in the presence of lithium.

Authors:  M L Laakso; S S Oja
Journal:  Neurochem Res       Date:  1979-06       Impact factor: 3.996

5.  Tryptophan transport across the synaptosomal membrane.

Authors:  D G Grahame-Smith; A G Parfitt
Journal:  J Neurochem       Date:  1970-09       Impact factor: 5.372

6.  Quantitative determination of soluble and membrane proteins through their native fluorescence.

Authors:  K Resch; W Imm; E Ferber; D F Wallach; H Fischer
Journal:  Naturwissenschaften       Date:  1971-04

7.  Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.

Authors:  D G Grahame-Smith
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

8.  Inhibition by L-phenylalanine of tyrosine transport by synaptosomal plasma membrane vesicles: implications in the pathogenesis of phenylketonuria.

Authors:  M C Aragón; C Giménez; F Valdivieso
Journal:  J Neurochem       Date:  1982-10       Impact factor: 5.372

9.  Glycine transport into plasma-membrane vesicles derived from rat brain synaptosomes.

Authors:  F Mayor; J G Marvizón; M C Aragón; C Gimenez; F Valdivieso
Journal:  Biochem J       Date:  1981-09-15       Impact factor: 3.857

10.  Tryptophan and phenylalanine transport in rat cerebral cortex slices as influenced by sodium ions.

Authors:  E R Korpi
Journal:  Neurochem Res       Date:  1980-04       Impact factor: 3.996

View more
  11 in total

1.  Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine.

Authors:  C Lykkelund; J B Nielsen; H C Lou; V Rasmussen; A M Gerdes; E Christensen; F Güttler
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

2.  Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.

Authors:  J Pietz; R Kreis; A Rupp; E Mayatepek; D Rating; C Boesch; H J Bremer
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Cross-sectional study of bone metabolism with nutrition in adult classical phenylketonuric patients diagnosed by neonatal screening.

Authors:  Hironori Nagasaka; Hirokazu Tsukahara; Tomozumi Takatani; Yoshitami Sanayama; Masaki Takayanagi; Toshihiro Ohura; Osamu Sakamoto; Tetsuya Ito; Mika Wada; Makoto Yoshino; Akira Ohtake; Tohru Yorifuji; Satoshi Hirayama; Takashi Miida; Hiroki Fujimoto; Hiroshi Mochizuki; Toshikazu Hattori; Yoshiyuki Okano
Journal:  J Bone Miner Metab       Date:  2011-05-19       Impact factor: 2.626

4.  Suckling rat brain regional distribution of Na+,K+-atpase activity in the in vitro galactosaemia: the effect of L-cysteine and glutathione.

Authors:  Kyriakoula Marinou; Stylianos Tsakiris; Christi Tsopanakis; Kleopatra H Schulpis; Panagiotis Behrakis
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

5.  The protective effect of L-cysteine and glutathione on the adult and aged rat brain (Na+,K+)-ATPase and Mg2+-ATPase activities in galactosemia in vitro.

Authors:  Stylianos Tsakiris; Haris Carageorgiou; Kleopatra H Schulpis
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

6.  Pattern-reversal visual evoked potentials in phenylketonuric children.

Authors:  A Landi; A Ducati; R Villani; R Longhi; E Riva; C Rodocanachi; M Giovannini
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

7.  Serotonin and noradrenaline concentrations and serotonin uptake in platelets from hyperphenylalaninaemic patients.

Authors:  M Giovannini; R Valsasina; R Longhi; A M Cesura; M D Galva; E Riva; G P Bondiolotti; G B Picotti
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

8.  Pattern reversal visual evoked potentials in phenylketonuria.

Authors:  M Giovannini; R Valsasina; R Villani; A Ducati; E Riva; A Landi; R Longhi
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

9.  Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents.

Authors:  H C Lou; F Güttler; C Lykkelund; P Bruhn; A Niederwieser
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

10.  Biochemical control, genetic analysis and magnetic resonance imaging in patients with phenylketonuria.

Authors:  J H Walter; L A Tyfield; J B Holton; C Johnson
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.